Old Mission Capital’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,198
Closed -$1.13M 1143
2024
Q3
$1.13M Buy
30,198
+11,520
+62% +$420K 0.02% 453
2024
Q2
$627K Buy
+18,678
New +$626K 0.01% 640

Other funds holding SBIO

Old Mission Capital's SBIO Position: Q4 2024 in Review

Old Mission Capital sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2024, closing a stake of 30,198 shares — an estimated $1.13M sold.

Old Mission Capital first reported a position in SBIO in Q2 2024 and held it in 2 quarters. The position peaked at $1.13M in Q3 2024. 35 funds tracked by Wall St. Rank hold SBIO as of Q4 2024.

  • Old Mission Capital reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2024 after selling out during the quarter.
  • Old Mission Capital sold 30,198 ALPS Medical Breakthroughs ETF shares in Q4 2024, an estimated $1.13M.
  • Old Mission Capital first reported a position in ALPS Medical Breakthroughs ETF in Q2 2024 and held it in 2 quarters.
  • Old Mission Capital's ALPS Medical Breakthroughs ETF position peaked at $1.13M in Q3 2024.
  • 35 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2024.

Based on Old Mission Capital's 13F filing for Q4 2024, filed 12 Feb 2025.